StemCorp

StemCorp is a Brazilian biotechnology company specializing in the processing, cryopreservation, and therapeutic application of mesenchymal stem cells (MSCs). Founded in 2013 and headquartered in São Paulo, the company operates a state-of-the-art GMP-certified laboratory dedicated to advancing regenerative medicine through high-quality cellular products. StemCorp offers specialized storage services for stem cells derived from umbilical cord tissue and dental pulp, while simultaneously developing a robust pipeline of cell therapy candidates. Its research focus includes treatments for osteoarthritis, type 1 diabetes, and various neurological conditions, often conducted in collaboration with leading medical institutions like Hospital Israelita Albert Einstein. By utilizing a proprietary cell expansion platform, StemCorp aims to provide scalable and standardized stem cell treatments to the Latin American market. The company is recognized as a pioneer in the Brazilian biotech sector, particularly for its work in dental pulp stem cell technology.